Study of an injected medicine for high lp(a) in adults
Part of Heart & circulation clinical trials.
This study tests an investigational medicine given by injection to lower Lp(a), a type of fat linked to heart disease. It may help people with high Lp(a) who already have heart problems or are at increased risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- A blood test must show you have high levels of lipoprotein(a), a type of fat in the blood that can raise your risk of heart problems.
- You must have heart or blood vessel disease, or be at moderate to high risk for it.
- If you take cholesterol-lowering drugs, your dose must stay the same during the study.
- You cannot have had a major heart event, surgery, or cancer in the recent past, and you must not be pregnant or planning pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
This study tests a new injected medicine called SAL0195 in healthy people to see if it is safe and how it works. It is especially for those with high levels of lipoprotein(a), a type of fat linked to heart disease.
This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.
This study tests an experimental oral medication, SAL0137, to see if it can lower Lp(a) levels, a type of fat in the blood linked to heart disease. It may help people who have high Lp(a) and are at increased risk for heart attacks or strokes.
This study looks at levels of a type of cholesterol called Lp(a) in people with certain heart and blood vessel diseases. The goal is to understand how common high Lp(a) is in Russian adults with these conditions.
This study tests a new medication called SYH2053 to see if it helps lower 'bad' cholesterol more effectively when added to your current statin therapy. It is for patients whose cholesterol is still not at their doctor's target level, and it aims to improve heart health.
Hear when a new Adult Participants With Elevated Lipoprotein(a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.